Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Affimed N.V.

Start price
Target price
Perf. (%)
€3.34
22.05.22
-
22.05.23
-68.81%
22.05.23

buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€0.94
20.05.22
-
20.05.23
-5.73%
11.06.22

buy
Exelixis Inc.

Start price
Target price
Perf. (%)
€16.46
19.05.22
-
19.05.23
3.22%
28.05.22

Chimerix Inc.

Start price
Target price
Perf. (%)
€2.00
19.05.22
-
19.05.23
-11.40%
24.05.22

Probably not worthwhile Investment
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.86
19.05.22
-
19.05.23
-5.52%
28.05.22

Risky Investment
buy
AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€4.80
18.05.22
€5.00
18.05.23
-45.86%
19.05.23

buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€3.16
18.05.22
€15.00
18.05.23
292.41%
29.07.22

Could be worthwhile Investment >10% per year
Higher risks for its business
Risky balance sheet
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.08
18.05.22
-
18.05.23
-3.43%
16.10.22

Risky Investment
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.08
18.05.22
-
18.05.23
10.77%
28.05.22

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€7.61
18.05.22
-
18.05.23
-14.51%
10.06.22

buy
Genocea Biosciences Inc.

Start price
Target price
Perf. (%)
€0.21
18.05.22
-
18.05.23
-92.86%
06.06.22

buy
Biofrontera AG

Start price
Target price
Perf. (%)
€1.16
18.05.22
-
18.05.23
2.59%
28.05.22

Could be very worthwhile Investment >20% year
Undervalued
buy
Chimerix Inc.

Start price
Target price
Perf. (%)
€1.61
16.05.22
-
16.06.22
11.05%
24.05.22

Some uniques
buy
Chimerix Inc.

Start price
Target price
Perf. (%)
€1.64
16.05.22
-
16.05.23
13.06%
28.05.22

Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€72.88
16.05.22
-
16.05.23
-2.92%
27.05.22

Probably not worthwhile Investment
Business model of the past or high risk
buy
Chimerix Inc.

Start price
Target price
Perf. (%)
€2.20
16.05.22
-
16.05.23
-15.61%
29.05.22

buy
Chimerix Inc.

Start price
Target price
Perf. (%)
€2.60
16.05.22
€3.00
16.05.23
-28.60%
28.05.22

Could be worthwhile Investment >10% per year
Capable Management
Little innovation
buy
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€2.99
16.05.22
-
16.05.23
-9.41%
28.05.22

buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€28.60
16.05.22
-
16.05.23
-14.58%
28.05.22

Risky Investment
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€59.87
15.05.22
€68.00
15.05.23
32.12%
28.10.22

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.37
15.05.22
-
15.05.23
-10.22%
24.09.22

Risky Investment
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€23.40
15.05.22
-
15.05.23
-19.97%
11.06.22

buy
Verastem Inc.

Start price
Target price
Perf. (%)
€11.88
15.05.22
-
15.05.23
1.03%
24.09.22

Could be very worthwhile Investment >20% year
buy
Pieris Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€1.68
15.05.22
-
15.05.23
-11.39%
04.09.22

buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€3.94
15.05.22
-
15.05.23
-16.75%
29.05.22